GlassScriptPhysician profile
Tyler Coye
NPI 1386205920
$821.62
in general payments reported to CMS, 2019-2025
9 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $48.58 · 2024: $541 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $275.25 | 2024-2025 | Stravix, Oasis, Grafix |
| Lifenet Health | $262.40 | 2024-2025 | Theragenesis Wound Matrix |
| Organogenesis INC. | $104.78 | 2024 | Puraply Am |
| Stryker Corporation | $45.29 | 2024 | Citrefix |
| Arthrosurface Incorporated | $43.37 | 2025 | Toe Motiontm |
| Polynovo North America LLC | $41.95 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $21.69 | 2023 | Tcc-Ez |
| Kerecis Limited | $21.54 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Advanced Oxygen Therapy INC. | $5.35 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Coye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.